Evidence map›Paper›PMID 35745822›Full record

ArticlePharmaceutics2022

Membrane Permeability and Aqueous Stability Study of Linear and Cyclic Diarylheptanoids from

Csenge Anna Felegyi-Tóth, Zsófia Tóth, Zsófia Garádi, Imre Boldizsár, Andrea Nagyné Nedves, Alexandra Simon, Kristóf Felegyi, Ágnes Alberti, Eszter Riethmüller

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Csenge Anna Felegyi-TóthDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Zsófia TóthDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Zsófia GarádiDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-0152-2746
Imre BoldizsárDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0001-7852-8364
Andrea Nagyné NedvesDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Alexandra SimonDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0001-8189-4170
Kristóf FelegyiDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Ágnes AlbertiDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Eszter RiethmüllerDepartment of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Semmelweis University · HU

Funding

Doctoral Student Scholarship Program of the Co-operative Doctoral Program of the Ministry of Innovation and Technology, financed by the National Research, Development and Innovation Fund KDP-1007075National Research, Development and Innovation Office (NKFIH) FK125302, K120342, K135712VEKOP-2.3.3-15-2017-00020, by the ELTE Thematic Excellence Programme 2020 Supported by National Research, Development and Innovation Office TKP2020-IKA-05
6 · The paper itself

Abstract

Seven diarylheptanoids were isolated from

Indexed as

absorptionalnusoneblood–brain barriergiffoninhazelmass spectrometryPAMPA

Identifiers

PMID35745822
PMCPMC9231376
OpenAlexW4282594117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.